Ozempic and Wegovy have received a lot of publicity as revolutionizing treatment options for obesity. Both medications form a class of GLP-1 receptor agonists, which mimic a hormone in the body called glucagon-like peptide-1 and are involved in the regulation of appetite and blood sugar. Indeed, in initial clinical studies, the majority of those on the drugs lost 15% to 22% of body weight, hence much optimism. For most patients, these medications are underwhelming for about 20% of patients due to minimal weight loss or other challenges.

Take a closer look at why the weight loss drugs may not work for everyone, together with what options exist when they don't deliver the expected outcomes.

Why Weight Loss Drugs May Not Work

While GLP-1 receptor agonists have produced phenomenal responses in a majority of patients, it remains a reality that these drugs work differently for different people. Here's why:

1. Genetic and Hormonal Variability

Weight loss medications interact with complex systems in the body that differ from person to person. Genetics, hormones, and individual brain responses to energy regulation play significant roles in determining how a person responds to drugs like Ozempic and Wegovy.

2. Underlying Medical Conditions

Other conditions, such as sleep apnea, may be prevalent and prevent or delay the achievement of weight loss goals. Prescription drugs like antidepressants, steroids, or contraceptives are other medications that can nullify weight loss medication benefits.

3. Unrealistic Expectations

Often, they come to these medications with enormous hopes; expecting the promised rapid and dramatic weight loss. Progress creates disappointment if it has not stalled. In patients who rigidly follow recommended lifestyle modifications, frustration and disappointment are most common.

Why it is Important to Identify Non-responders

For most patients, the effectiveness of GLP-1 receptor agonists is evident within a few weeks of treatment. Weight loss typically begins within a few weeks of initiating therapy and tends to increase with dosage. However, some patients respond very little, if at all, despite strict adherence to their regimen.

For nonresponders, this can feel like a dead end. However, understanding the unique complexities of obesity is essential. This condition stems from brain dysfunction, and the pathways that contribute to weight regulation differ among individuals.

Alternative Treatment Options

When Ozempic or Wegovy doesn’t yield desired results, there are still many paths to explore:

1. Switching to Another GLP-1 Drug

For example, some patients who don't respond well to one GLP-1 receptor agonist might find success with another drug in the same class. Newer medications, such as Zepbound, target other hormone pathways and seem promising even for those not responsive to earlier drugs.

2. Use of Older Medications

While there is much to say about newer drugs, older treatments can still be useful and work for some patients. One can also seek the help of a medical provider specializing in obesity treatments in order to identify the best alternatives.

3. Lifestyle Changes

Diet, exercise, sleep, and stress management continue to be integral components of any weight loss program. New changes may be small but can make an enormous difference in one's health and success.

4. Medical Management of Obesity

It is a complex disorder, and most patients should receive a multidisciplinary treatment. Collaboration with an obesity-aware doctor may mean access to tailored treatment plans, ranging from psychological support all the way to metabolic testing, and many others.

Why Side Effects of Weight Loss Drug Ozempic May Be a Barrier

For others, side effects like nausea, vomiting, or diarrhea hinder them from continuing with these drugs. These symptoms often reduce as the body becomes accustomed, but for some, they might be severe enough to stop treatment altogether. In those instances, alternative drugs or procedures become vital to find.

Long-term effects of Ozempic or Wegovy on the Brain

Another largely unexplored area relates to GLP-1 drugs' long-term effects on the brain's regulation of hunger and satiety. Although GLP-1 drugs suppress appetite and can lead to effective weight loss, emerging research suggests that they may also affect brain reward mechanisms, changing the way patients experience foods.

This aspect could prove of paramount significance in the future treatment of obesity. Perhaps GLP-1 receptor agonists do indeed affect and rewire the brain's reward pathways and will thus provide sustained benefits beyond discontinuation. However, more research is required to understand this phenomenon fully.

While for many, Ozempic and Wegovy have revolutionized obesity treatment, these are certainly not a one size fits all. Nonresponders need not lose hope- alternative strategies and medications abound. A consultation with an obesity expert healthcare provider is essential to put together a comprehensive, tailored treatment plan.

The route toward effective weight loss may be challenging, but with the evolution of obesity medicine and a better understanding of individual needs, there is a path forward for everyone.

A new global analysis by the World Health Organization and its cancer research arm, the International Agency for Research on Cancer, has found that prevention could dramatically reduce cancer cases worldwide. The report estimates that 37 percent of all new cancers in 2022, about 7.1 million cases, were linked to causes that can largely be avoided.

The findings are based on data from 185 countries and 36 cancer types and were released ahead of World Cancer Day. Researchers examined 30 risk factors including tobacco use, alcohol, obesity, lack of physical activity, air pollution, ultraviolet radiation and nine cancer causing infections. The report stresses that prevention may be the single most powerful tool available to reduce the global cancer burden.

According to WHO data, tobacco remains the biggest contributor, responsible for about 15 percent of all new cancer cases globally. Infections accounted for around 10 percent while alcohol contributed to roughly 3 percent. Three cancers together made up nearly half of all preventable cases worldwide. Lung cancer was strongly linked to smoking and polluted air, stomach cancer to Helicobacter pylori infection, and cervical cancer to human papillomavirus infection.

WHO cancer control experts said the analysis shows clearly how much cancer risk comes from factors people and governments can act on before the disease even develops.

Differences between men, women and regions

The report shows clear gender differences. Preventable cancer accounted for 45 percent of new cases among men compared with 30 percent among women. Among men, smoking alone contributed to 23 percent of new cancers followed by infections at 9 percent and alcohol at 4 percent. Among women, infections were the largest contributor at 11 percent, followed by smoking at 6 percent and high body mass index at 3 percent.

The burden also varied widely across regions. In women, preventable cancers ranged from 24 percent in North Africa and West Asia to 38 percent in sub Saharan Africa. Among men, East Asia had the highest share at 57 percent while Latin America and the Caribbean recorded the lowest at 28 percent. Researchers say these differences reflect lifestyle habits, environmental exposures, workplace safety standards and public health policies.

The WHO report highlights practical steps that could reduce cancer cases. These include stronger tobacco control laws, limits on alcohol use, vaccination against HPV and hepatitis B, improved air quality, safer workplaces and promotion of healthier diets and physical activity.

Health officials say coordinated action across sectors such as transport, education, labour and energy can prevent millions of cancer diagnoses and lower long term healthcare costs while improving overall population health.

Reality television personality Nicole “Snooki” Polizzi has revealed she has been diagnosed with stage-one cervical cancer after undergoing further testing for previously detected abnormal cells.

The Jersey Shore alum shared in a Feb. 20 TikTok video that a cone biopsy confirmed adenocarcinoma, a type of cancer that develops in gland-lining cells. Doctors discovered the disease less than a month after she first announced the presence of cancerous cervical cells.

“Not the news I was hoping for,” the 38-year-old said, adding that the early detection significantly improved her outlook.

Detected Early After Years Of Tests

Polizzi said she had experienced abnormal Pap smear results for several years before undergoing the procedure that led to the diagnosis. She encouraged followers not to delay screenings out of fear or discomfort, noting early detection made the cancer potentially curable.

Medical teams also informed her that the cancer had not spread deeper into the cervix — an encouraging sign — though adenocarcinoma can be more aggressive and may spread to lymph nodes if untreated.

Further Scans And Likely Surgery

Doctors have scheduled a PET scan to determine whether the cancer has spread elsewhere in the body. Depending on the findings, treatment options include chemotherapy, radiation or surgery.

Polizzi said she is leaning toward a hysterectomy, the surgical removal of the uterus, describing it as the most sensible course of action.

Message to Fans: Don’t Skip Screenings

The television star, a mother of three, thanked supporters for their encouragement and said she plans to keep sharing updates during treatment.

She also stressed the importance of routine check-ups, calling cervical cancer “nothing to joke about” and urging people to seek timely testing, even when it feels uncomfortable or frightening.

What Is Cervical Cancer?

Cervical cancer, also known as cancer of the cervix, begins on the surface of the cervix and involves the growth of abnormal cells in its lining. Cervical cancer is primarily caused by infection with the human papillomavirus (HPV), which is preventable with a vaccine.

There are three main types of cervical cancer:

• Squamous cell carcinoma: This type forms in the lining of the cervix and accounts for about 70% of cases.
• Adenocarcinoma: This type forms in the cells that produce mucus and is less common.
• Mixed carcinoma: This type has features of both squamous cell carcinoma and adenocarcinoma.

Preventive measures, including the HPV vaccine and regular screenings, are crucial in reducing the risk of cervical cancer. Early detection and treatment significantly improve the chances of successful outcomes.

Symptoms of Cervical Cancer

In its early stages, cervical cancer typically doesn’t show any symptoms, which is why regular screening is important to catch it at this stage. Once symptoms do start appearing, they include abnormal vaginal bleeding (in between periods) and unusual vaginal discharge. Pain during sex in the pelvic region is another common symptom. As the cancer worsens, patients may experience more severe symptoms like weight loss, fatigue and leg swelling.

Precancerous changes in cervical cells rarely cause symptoms. The only way to detect abnormal cells that may develop into cancer is through a cervical screening test. If these early cell changes progress into cervical cancer, the most common signs include:

• Vaginal bleeding between periods
• Menstrual bleeding that is longer or heavier than usual
• Pain during intercourse
• Bleeding after intercourse
• Pelvic pain
• Changes in vaginal discharge, such as increased discharge or discharge with a strong or unusual color or smell
• Vaginal bleeding after menopause

These symptoms can be caused by other conditions, but if you are worried or symptoms persist, it is essential to contact your doctor. This is important for anyone with a cervix, including individuals who are straight, lesbian, gay, bisexual, or transgender.

Early signs of cervical cancer can include:

• Pain during sex
• Unusual vaginal bleeding, such as after sex, between periods, after menopause, or following a pelvic exam
• Unusual vaginal discharge that is watery, bloody, and/or has a strong odour

As cervical cancer progresses, it can cause additional symptoms, such as:

• Pelvic pain
• Trouble urinating
• Swollen legs
• Kidney failure
• Bone pain
• Weight loss and lack of appetite
• Fatigue
• Backache
• Stomach pain

It is crucial to note that you might not notice symptoms of cervical cancer until it has advanced. Regular screenings and prompt medical consultation for any concerning symptoms are vital for early detection and effective treatment.

Adolescents who use cannabis could face a significantly higher risk of developing psychotic (doubled), bipolar (doubled), depressive and anxiety disorders, a study shows.

Researchers from Kaiser Permanente, the Public Health Institute's Getting it Right from the Start, the University of California, San Francisco and the University of Southern California, who studied 463,396 adolescents ages 13 to 17 through age 26, found that children between these ages were extremely prone to developing mental illnesses.

Lynn Silver, MD, program director of the Getting it Right from the Start, a program of the Public Health Institute, and study co-author noted: "As cannabis becomes more potent and aggressively marketed, this study indicates that adolescent cannabis use is associated with double the risk of incident psychotic and bipolar disorders, two of the most serious mental health conditions.

"The evidence increasingly points to the need for an urgent public health response - one that reduces product potency, prioritizes prevention, limits youth exposure and marketing and treats adolescent cannabis use as a serious health issue, not a benign behavior."

"Even after accounting for prior mental health conditions and other substance use, adolescents who reported cannabis use had a substantially higher risk of developing psychiatric disorders - particularly psychotic and bipolar disorders.

"This study adds to the growing body of evidence that cannabis use during adolescence could have potentially detrimental, long-term health effects. It's imperative that parents and their children have accurate, trusted, and evidence-based information about the risks of adolescent cannabis use," Kelly Young-Wolff, Ph.D., lead author of the study and senior research scientist at the Kaiser Permanente Division of Research, added.

The observational US-focused study also found that cannabis use was more common among adolescents enrolled in Medicaid and those living in more socioeconomically deprived neighborhoods.

How Does Cannabis Usage In Teens Affect Overall Health?

Strong links have also been found between adolescent cannabis use and mental health issues, including increased risk of depression, anxiety, and, in some cases, schizophrenia or other psychotic disorders.

Additionally, smoking cannabis can lead to breathing problems similar to tobacco, such as chronic bronchitis. It can also cause an increased heart rate, and some studies suggest a higher risk of heart attacks.

Early initiation, especially before age 16, increases the risk of developing Cannabis Use Disorder (addiction). High-potency products can lead to rapid onset of withdrawal symptoms, mood changes, and even physical complications like Cannabis Hyperemesis Syndrome (severe nausea/vomiting)

Why Should Early Cannabis Usage Be Discouraged?

Compared to teens who don't use cannabis, those who do are more likely to drop out of high school or not finish a college degree. Using cannabis can cause several immediate and long-term problems for teens:

• Difficulty Thinking
• Memory Issues
• Poor Coordination
• Attention Problems
• School and Social Troubles
• Cannabis use can also lead to more serious issues that affect a teen's overall life.
• Increased Mental Health Risks

Driving under the influence of cannabis is illegal and unsafe, as it severely slows reaction time. Cannabis reduces coordination and concentration, impacting all the skills necessary for responsible and safe driving.

Around 30 percent of cannabis users are also known to develop an addiction (cannabis use disorder). Failing to quit or choosing the drug over family activities are signs. This risk is higher for frequent teen users.